Infliximab use in Crohn's disease:impact on health care resources in the UK

Jewell, Derek P, Satsangi, Jack, Lobo, Alan, Probert, Christopher, Forbes, Alastair ORCID: https://orcid.org/0000-0001-7416-9843, Ghosh, Subrata, Shaffer, Jon, Frenz, Markus, Drummond, Hazel, Troy, Gill, Turner, Sue, Younge, Lisa, Evans, Lyn, Moosa, Mark, Rodgers-Gray, Barry and Buchan, Scot (2005) Infliximab use in Crohn's disease:impact on health care resources in the UK. European Journal of Gastroenterology & Hepatology, 17 (10). pp. 1047-52. ISSN 0954-691X

Full text not available from this repository. (Request a copy)

Abstract

To quantify the impact of infliximab therapy on health care resource utilization in the UK.

Item Type:	Article
Uncontrolled Keywords:	adolescent,adult,aged,aged, 80 and over,antibodies, monoclonal,antirheumatic agents,cost-benefit analysis,crohn disease,drug costs,epidemiologic methods,female,great britain,health care costs,health resources,health services research,hospitalization,humans,male,middle aged,treatment outcome,tumor necrosis factor-alpha
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User:	Pure Connector
Date Deposited:	06 Aug 2014 10:48
Last Modified:	20 Oct 2022 23:59
URI:	https://ueaeprints.uea.ac.uk/id/eprint/49639
DOI:

Actions (login required)

View Item